ArticleCurrent neuropharmacology2025

Partial Dopamine D2/3 Agonists and Dual Disorders: A Retrospective-Cohort Study in a Real-World Clinical Setting on Patients with Schizophrenia Spectrum Disorders and Cannabis Use Disorder.

Giada Trovini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.